

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PDGFR ↓ ↑ | PDGFRα ↓ ↑ | PDGFRβ ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tyrphostin A9 |
+
PDGFR, IC50: 0.5 μM |
EGFR | 98% | ||||||||||||||||
| Tyrphostin AG1296 | 99%+ | ||||||||||||||||||
| Motesanib Diphosphate |
++
PDGFR, IC50: 84 nM |
97% | |||||||||||||||||
| Pazopanib |
++
PDGFR, IC50: 84 nM |
99% | |||||||||||||||||
| Imatinib |
+
PDGFR, IC50: 100 nM |
c-Kit | 98% | ||||||||||||||||
| Imatinib Mesylate |
+
PDGFR, IC50: 100 nM |
c-Kit | 99% | ||||||||||||||||
| Sennoside B | ✔ | 99%+ | |||||||||||||||||
| PP121 |
++++
PDGFR, IC50: 2 nM |
VEGFR,mTOR | 99%+ | ||||||||||||||||
| Crenolanib |
++++
PDGFRα, Kd: 2.1 nM |
++++
PDGFRβ, Kd: 3.2 nM |
99%+ | ||||||||||||||||
| Masitinib |
+
PDGFRα, IC50: 540 nM |
+
PDGFRβ, IC50: 800 nM |
99%+ | ||||||||||||||||
| Ki8751 |
++
PDGFRα, IC50: 67 nM |
c-Kit | 99% | ||||||||||||||||
| Tivozanib |
++
PDGFRα, IC50: 40 nM |
++
PDGFRβ, IC50: 49 nM |
99%+ | ||||||||||||||||
| Ponatinib |
++++
PDGFRα, IC50: 1.1 nM |
98% | |||||||||||||||||
| Amuvatinib |
++
PDGFRα (V561D), IC50: 40 nM |
99%+ | |||||||||||||||||
| Axitinib |
+++
PDGFRα, IC50: 5.0 nM |
++++
PDGFRβ, IC50: 1.6 nM |
98% | ||||||||||||||||
| CP-673451 |
+++
PDGFRα, IC50: 10 nM |
++++
PDGFRβ, IC50: 1 nM |
99%+ | ||||||||||||||||
| Telatinib |
+++
PDGFRα, IC50: 15 nM |
c-Kit | 99%+ | ||||||||||||||||
| Nintedanib |
++
PDGFRα, IC50: 59 nM |
++
PDGFRβ, IC50: 65 nM |
99+% | ||||||||||||||||
| Avapritinib |
++++
PDGFRα (D842V), IC50: 0.5 nM |
99%+ | |||||||||||||||||
| MK-2461 |
+++
PDGFRβ, IC50: 22 nM |
98%+ | |||||||||||||||||
| Lactate |
+++
PDGFRβ, IC50: 27 nM |
c-Kit,FLT3 | 85% | ||||||||||||||||
| Linifanib |
++
PDGFRβ, IC50: 66 nM |
99%+ | |||||||||||||||||
| AZD2932 |
+++
PDGFRβ, IC50: 4 nM |
c-Kit | 99% | ||||||||||||||||
| Dovitinib |
+++
PDGFRβ, IC50: 27 nM |
c-Kit,FLT3 | 99%+ | ||||||||||||||||
| Sorafenib |
++
PDGFRβ, IC50: 57 nM mPDGFRβ, IC50: 57 nM |
99% | |||||||||||||||||
| Sunitinib |
++++
PDGFRβ , IC50: 2 nM |
FLT3 | 98% | ||||||||||||||||
| Orantinib |
+++
PDGFRβ, Ki: 8 nM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Sennoside B can inhibit PDGF-stimulated cell proliferation by binding to PDGF(platelet-derived growth factor)-BB and its receptor and by down-regulating the PDGFR-beta signaling pathway[3]. The 50% inhibitory concentrations of the four sennosides (A, B, E and F) were 17, 9, 24 and 13 microM, respectively, and the type of inhibition by seenosides A and B with respect to allylamine as the substrate was non-competitive[4]. Intracaecal administration of rhein anthrone, the intraluminally active metabolite of sennosides A and B, to mice quickly induced severe diarrhoea[5]. From acute studies, sennosides could be classified as only slightly toxic in rats and mice after a single oral dose. The LD50 values were about 5,000 mg/kg in both species. In subacute studies with rats (max. 20 mg/kg) and dogs (max. 500 mg/kg), sennosides caused no specific local or systemic toxicity[6]. |
| Concentration | Treated Time | Description | References | |
| C8166 cells | C8166 cells | To evaluate the inhibitory activity of SA and SB against HIV-1-induced cytopathic effects (CPE). Results showed an IC50 of 4.73 μM for SB. | Front Microbiol. 2023 Sep 25;14:1270258. | |
| L929 cells | L929 cells | To evaluate the inhibitory effect of Sennoside B on TNF-α-induced L929 cell toxicity, results showed 80.3% inhibition at 100 µM concentration | Biomedicines. 2021 Sep 17;9(9):1250. | |
| HeLa cells | HeLa cells | To evaluate the inhibitory effect of Sennoside B on TNF-α-induced HeLa cell toxicity, results showed an IC50 value of 0.32 µM | Biomedicines. 2021 Sep 17;9(9):1250. | |
| AGS gastric cells | AGS gastric cells | To evaluate the effect of Sennoside B on PGE2 production, results showed that Sennoside B increased PGE2 concentration in a dose-dependent manner. | Biomol Ther (Seoul). 2015 Sep;23(5):458-64. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | C57BL/6 mice | Intraperitoneal injection | 9.3 mg/kg | Single injection, followed by injection of Ag-treated B cells after 2 hours | To evaluate the inhibitory effect of Sennoside B on antigen transfer between B cells and macrophages/dendritic cells in vivo, results showed that Sennoside B significantly reduced antigen transfer, comparable to SR-A-deficient mice. | J Biol Chem. 2012 Feb 17;287(8):5310-6 |
| Sprague-Dawley rats | HCl•EtOH-induced gastritis and indomethacin-induced gastric ulcer models | Oral | 100 mg/kg | Single dose, 30 minutes before inducing gastritis or gastric ulcer | To evaluate the gastroprotective effects of Sennoside B, results showed that Sennoside B significantly reduced lesion indices, inhibited gastric acid secretion, and increased gastric juice pH. | Biomol Ther (Seoul). 2015 Sep;23(5):458-64. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.16mL 0.23mL 0.12mL |
5.80mL 1.16mL 0.58mL |
11.59mL 2.32mL 1.16mL |
|
| CAS号 | 128-57-4 |
| 分子式 | C42H38O20 |
| 分子量 | 862.74 |
| SMILES Code | O=C1C2=C(O)C=C(C(O)=O)C=C2[C@@H](C3=C1C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)=CC=C3)[C@@H](C5=C6C(O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)=CC=C5)C8=CC(C(O)=O)=CC(O)=C8C6=O |
| MDL No. | MFCD00151528 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | IPQVTOJGNYVQEO-AIFLABODSA-N |
| Pubchem ID | 91440 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(121.71 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1